Cargando…
Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab
A search of the scientific literature for Daratumumab and myeloma gives more than 600 results (January 2021), which reflects the interest and activity around this antibody, an interest that was also reflected by the assignment of breakthrough designation for Daratumumab as a treatment for multiple m...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958124/ https://www.ncbi.nlm.nih.gov/pubmed/33801271 http://dx.doi.org/10.3390/jcm10051002 |